We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ITHA:NASDAQITHAX Acquisition Corp III Analysis

Data as of 2026-05-20 - not real-time

$9.98

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at its 52‑week high of $9.98 with an RSI of 89, indicating extreme overbought conditions, while the MACD remains bullish but with a very narrow histogram. Volume is sharply decreasing (14 shares today versus an average of 860 over ten days), suggesting waning buying pressure despite the Extreme Greed sentiment reflected in the fear‑greed index. The price sits just above the 20‑day SMA (9.94) and the longer‑term SMAs, reinforcing a short‑term bullish bias, yet the near‑zero beta and 1.25% 30‑day volatility imply the move is largely isolated from broader market swings. Fundamentally, ITHA has zero revenue, negative book value per share (-$0.288) and a price‑to‑book ratio of -34.65, with only $0.65 M in cash and no debt, highlighting a pure SPAC structure with no operating assets. The lack of earnings, margins, and cash flow combined with a negative PB ratio underscores a severe valuation disconnect from the current price. Consequently, while technicals appear temporarily supportive, the underlying fundamentals and the speculative nature of the pending business combination drive substantial upside/downside risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • RSI in overbought territory (89)
  • Sharp decline in trading volume
  • No operating earnings or cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Uncertainty around the upcoming merger or acquisition
  • Current overvaluation relative to assets
  • Technical bullish bias but limited fundamental support

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential value creation if a successful business combination occurs
  • Persistently negative book value and lack of revenue
  • Low market beta and modest volatility indicating limited systemic risk

Key Metrics & Analysis

Financial Health

P/B Ratio-34.7
Op. Cash Flow$-682960
Industry P/E16.7

Technical Analysis

TrendBullish
RSI89.1
Support$9.92
Resistance$9.98
MA 20$9.94
MA 50$9.91
MA 200$9.91
MACDBullish
VolumeDecreasing
Fear & Greed Index90.29

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta-0.02
Volatility1.25%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.